Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nature’s Valley Women’s Multi Lacks Child-Resistant Cap – Leiner/CPSC

This article was originally published in The Tan Sheet

Executive Summary

Leiner is posting recall alerts for its Nature's Valley Women's Formula Multivitamin in vitamin aisles of select Albertson's, Jewel, Osco, Sav-on and Acme stores alerting consumers the product is "without a child-resistant cap.

You may also be interested in...



Leiner Corrective Actions, Meeting With FDA Follows Warning Letter

Leiner Health Products is implementing a corrective action plan to deal with current Good Manufacturing Practices violations at the company's repackaging and distribution facilities in Carson, Calif.

NHA challenges iron unit-dose packaging requirements in law suit against FDA.

NHA CHALLENGES UNIT-DOSE PACKAGING REQUIREMENTS FOR IRON -containing dietary supplements and drugs in a suit filed against FDA Aug. 29 in Manhattan district court. The Nutritional Health Alliance, represented by Bass & Ullman, New York City, claims that FDA exceeded its regulatory authority by issuing the regs. The final rule, published in the Jan. 15 Federal Register, requires unit-dose packaging and label warnings for all solid oral dosage form dietary supplements and drug products containing 30 mg or more iron ("The Tan Sheet" Jan. 20, pp. 1-4). FDA must file a response to NHA's complaint by Oct. 31.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS093763

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel